January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreMay 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
Based on market forecasts, the alzheimer’s therapeutics sector will expand from USD 5.7 billion in 2025 to USD 13.13 billion by 2035, experiencing a CAGR of 8.7%. In 2024, North America led the market, while Asia-Pacific is set for the fastest growth ahead. Cholinesterase inhibitors dominated by product, but pipeline drugs are expected to gro...
April 21, 2026
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital pharmacies dominated distribution at 50%. North America was the top region. Key players include ViiV...
April 21, 2026
According to forecasts, the global alopecia areata market will grow from USD 3.32 billion in 2024 to USD 6.92 billion by 2034, with an expected CAGR of 7.6%. AI is transforming the Alopecia Areata market by improving diagnosis, treatment, and research. It enables early detection through advanced analysis, allowing for timely intervention. AI also a...
April 21, 2026
According to market projections, the global multiple sclerosis diagnosis and treatment market, valued at USD 22.89 billion in 2024, is anticipated to reach USD 31.98 billion by 2034, growing at a CAGR of 3.4% over the next decade. Advancements in technology aid early diagnosis and better prevention for multiple sclerosis (MS), reducing its economic...
April 21, 2026
Market insights predict the global cervical spondylosis diagnosis and treatment industry will increase from USD 6.63 billion in 2024 to USD 12.67 billion by 2034, achieving a CAGR of 6.7%. In 2023, medications dominated the Cervical Spondylosis Diagnosis & Treatment Market with a 38% share, while hospital pharmacies led with 40%. The Asia Pacif...
April 21, 2026
Based on market forecasts, the osteoarthritis sector will expand from USD 9.32 billion in 2024 to USD 20.88 billion by 2034, experiencing a CAGR of 8.4%. In 2023, knee osteoarthritis led the market with a 49% share due to its high prevalence. Imaging tests dominated diagnostics, while North America held a 38% market share. Key players include Zimme...
April 21, 2026
According to forecasts, the global respiratory drugs market will grow from USD 17.53 billion in 2024 to USD 30.81 billion by 2034, with an expected CAGR of 5.8%. In 2023, COPD was the most common respiratory disorder, leading the market with a 36% share. Bronchodilators dominated treatment options with a 40% share. Hospital pharmacies were the top ...
April 21, 2026
The carpal tunnel syndrome market is growing due to rising cases linked to arthritis, hormonal changes, and more. Innovations like AI improve detection, while ongoing research drives new treatments. Regional trends vary, with North America focusing on awareness and Asia Pacific tackling underdiagnosis challenges....
April 21, 2026
Market insights predict, the epilepsy drugs industry is expected to grow from USD 9.98 billion in 2024 to USD 16.42 billion by 2034, driven by a CAGR of 5.1%. Epilepsy drugs help control seizures by stabilizing brain activity. They work by reducing excessive nerve signaling, preventing sudden electrical bursts that cause seizures. These medications...
April 21, 2026
According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophrenia and bipolar disorder. They work by balancing brain chemicals to reduce hallucinations, delusions, ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
